Literature DB >> 19591522

Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey.

Pascale Olivier1, Lionel Bertrand, Marie Tubery, Dominique Lauque, Jean-Louis Montastruc, Maryse Lapeyre-Mestre.   

Abstract

BACKGROUND AND OBJECTIVES: Several studies have been conducted to determine the frequency and characteristics of adverse drug reactions (ADRs) in elderly populations, focusing on those leading to hospital admission. However, most of these studies have been limited in their ability to assess risk factors, particularly the renal status of patients. Thus, the aim of this prospective study was to assess the incidence of ADRs and associated factors leading to hospital admissions in the elderly population.
METHODS: All patients aged > or =65 years admitted to the Toulouse University Hospital through the Emergency Department during four non-consecutive weeks in 2002-3 were included in this study except for patients in ambulatory care or admitted for intentional overdoses. The characteristics of patients admitted for a suspected ADR were compared with those of patients admitted for other reasons.
RESULTS: The incidence of hospital admissions for ADRs was 8.37 per 100 admissions (95% CI 6.52, 10.52), corresponding to 66 patients with ADRs among 789 admissions. The most important factors associated with ADRs were the number of drugs being taken (odds ratio [OR] 1.18; 95% CI 1.08, 1.29), self-medication (OR 2.34; 95% CI 1.18, 4.66), use of antithrombotics (Anatomic Therapeutic and Chemical [ATC] classification B01; OR 2.26; 95% CI 1.33, 3.88) and use of antibacterial drugs (ATC J01; OR 4.04; 95% CI 1.50, 10.83). Surprisingly, exposure to drugs for acid-related disorders was associated with a low risk of ADRs (OR 0.26; 95% CI 0.09, 0.76).
CONCLUSION: A significant incidence of ADRs leading to hospital admissions was found among elderly people. Our study showed that there is a need to increase the availability of information for the general public concerning potential ADRs due to self-medication and for prescribers concerning ADRs due to drug-drug interactions and polypharmacy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591522     DOI: 10.2165/00002512-200926060-00004

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  28 in total

Review 1.  Hospitalisations and emergency department visits due to drug-drug interactions: a literature review.

Authors:  Matthijs L Becker; Marjon Kallewaard; Peter W J Caspers; Loes E Visser; Hubert G M Leufkens; Bruno H Ch Stricker
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-06       Impact factor: 2.890

Review 2.  Potential adverse effects of proton pump inhibitors.

Authors:  Gregory A Coté; Colin W Howden
Journal:  Curr Gastroenterol Rep       Date:  2008-06

3.  Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA).

Authors:  Graziano Onder; Claudio Pedone; Francesco Landi; Matteo Cesari; Cecilia Della Vedova; Roberto Bernabei; Giovanni Gambassi
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

4.  National surveillance of emergency department visits for outpatient adverse drug events.

Authors:  Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

5.  Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients.

Authors:  Andrea Corsonello; Claudio Pedone; Francesco Corica; Chiara Mussi; Pierugo Carbonin; Raffaele Antonelli Incalzi
Journal:  Arch Intern Med       Date:  2005-04-11

6.  Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.

Authors:  A Pilotto; M Franceschi; G Leandro; F Paris; L Cascavilla; M G Longo; V Niro; A Andriulli; C Scarcelli; F Di Mario
Journal:  Aliment Pharmacol Ther       Date:  2004-11-15       Impact factor: 8.171

7.  Contribution of adverse drug reactions to hospital admission of older patients.

Authors:  C K Mannesse; F H Derkx; M A de Ridder; A J Man in 't Veld; T J van der Cammen
Journal:  Age Ageing       Date:  2000-01       Impact factor: 10.668

8.  High prevalence of unknown co-medication in hospitalised patients.

Authors:  Karin Rieger; André Scholer; Isabelle Arnet; Frank T Peters; Hans H Maurer; Ingeborg Walter-Sack; Walter E Haefeli; Meret Martin-Facklam
Journal:  Eur J Clin Pharmacol       Date:  2004-06-10       Impact factor: 2.953

Review 9.  Drug-related hospital admissions.

Authors:  T R Einarson
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

10.  Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.

Authors:  Marilisa Franceschi; Carlo Scarcelli; Valeria Niro; Davide Seripa; Anna Maria Pazienza; Giovanni Pepe; Anna Maria Colusso; Luigi Pacilli; Alberto Pilotto
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more
  54 in total

1.  Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors.

Authors:  E Pappa; N Kontodimopoulos; A A Papadopoulos; Y Tountas; D Niakas
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

Review 2.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

3.  Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features.

Authors:  Consuelo Pedrós; Francesc Formiga; Xavier Corbella; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2015-11-07       Impact factor: 2.953

4.  Drug Burden Index and hospitalization among community-dwelling older people.

Authors:  Eija Lönnroos; Danijela Gnjidic; Sarah N Hilmer; J Simon Bell; Hannu Kautiainen; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

Review 5.  Medical and surgical complications of inflammatory bowel disease in the elderly: a systematic review.

Authors:  Dennis L Shung; Bincy Abraham; Joseph Sellin; Jason K Hou
Journal:  Dig Dis Sci       Date:  2014-12-12       Impact factor: 3.199

6.  Is it time to revise linezolid dose in elderly patients?

Authors:  Marco Tinelli; Cristina Gervasoni; Manuela Piazza; Roberta Terzi; Valeria Cozzi; Elena Maffezzini; Chiara Cerri; Simone Castoldi; Sara Baldelli; Dario Cattaneo
Journal:  Eur J Clin Pharmacol       Date:  2017-07-15       Impact factor: 2.953

Review 7.  Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis.

Authors:  T J Oscanoa; F Lizaraso; Alfonso Carvajal
Journal:  Eur J Clin Pharmacol       Date:  2017-03-01       Impact factor: 2.953

Review 8.  [Decision aids in complex polypharmacy : Medication data bases and counselling by clinical pharmacists].

Authors:  W Weinrebe; R Preda; S Bischoff; D Nussbickel; M Humm; K Jeckelmann; S Goetz
Journal:  Z Gerontol Geriatr       Date:  2017-07-18       Impact factor: 1.281

9.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

10.  Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study.

Authors:  Sven Schmiedl; Marietta Rottenkolber; Joerg Hasford; Dominik Rottenkolber; Katrin Farker; Bernd Drewelow; Marion Hippius; Karen Saljé; Petra Thürmann
Journal:  Drug Saf       Date:  2014-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.